LEADER 01233nam  2200337Ia 450 
001 9910699050503321
005 20090821143622.0
035   $a(CKB)5470000002399381
035   $a(OCoLC)432329182
035   $a(EXLCZ)995470000002399381
100   $a20090821d2003      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eIRB review of stand-alone HIPAA authorizations under FDA regulations
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner,$d[2003]
215   $a1 online resource (10 pages)
300   $a"Final guidance".
300   $a"October 21, 2003."
517   $aGuidance for industry 
606   $aInstitutional review boards (Medicine)$xGovernment policy$zUnited States
615  0$aInstitutional review boards (Medicine)$xGovernment policy
712 02$aUnited States.$bFood and Drug Administration.$bOffice of the Commissioner.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699050503321
996   $aGuidance for industry$93434577
997   $aUNINA